Nucleotides (NTs) as an anti-aging supplement may improve sleep quality in older adults, but efficacy is not yet established.
The TALENTs trial enrolled 122 adults aged 60-70 years to evaluate nucleotides as an anti-aging supplement. Baseline data showed nearly half of participants had room for improvement in sleep quality, but results on NT effects are pending.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Nucleotides (NTs) as an anti-aging supplement may improve sleep quality in older adults, but efficacy is not yet established. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
Nucleotides (NTs) as an anti-aging supplement may improve sleep quality in older adults, but efficacy is not yet established.
This conclusion is most relevant to: Community-dwelling older adults aged 60-70 years, predominantly female (67.21%), with pre-frailty and at least one chronic condition.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Targeting Aging and Longevity with Exogenous Nucleotides (TALENTs): Rationale, Design, and Baseline Characteristics from a Randomized Controlled Trial in Older Adults. (Nutrients, 2024) —
How It Works
The proposed biological pathway:
- ▸Nucleotides are involved in cellular processes
- ▸May influence aging pathways
- ▸Potential to improve sleep quality
- ▸Result pending from trial
Who Might Benefit
Evidence fit by population:
- ▸Community-dwelling older adults aged 60-70 years, predominantly female (67.21%), with pre-frailty and at least one chronic condition
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Baseline data only; no intervention results reported
- ▸Sleep quality was a secondary outcome, not primary
- ▸Nearly half of participants had room for improvement, but normal range suggests ceiling effect
Frequently Asked Questions
What is the TALENTs trial about?▼
It is a randomized, double-blinded, placebo-controlled trial testing nucleotides as an anti-aging supplement in older adults aged 60-70.
Does this paper show that nucleotides improve sleep?▼
No, the paper only reports baseline characteristics; sleep quality was measured but results from the intervention are not yet available.
Who were the participants in this study?▼
122 community-dwelling adults aged 60-70, mostly female (67.21%), with pre-frailty and at least one chronic condition.
What outcomes were measured besides sleep?▼
Primary outcomes were leukocyte telomere length and DNA methylation age; secondary outcomes included immunity, inflammation, oxidative stress, physical function, and cognition.
References
- 1.Wang S, Song L, Fan R, Chen Q, You M, Cai M, Wu Y, Li Y, Xu M. “Targeting Aging and Longevity with Exogenous Nucleotides (TALENTs): Rationale, Design, and Baseline Characteristics from a Randomized Controlled Trial in Older Adults..” Nutrients, 2024. PMID: 38732590 DOI: 10.3390/nu16091343